Curcumin Offers No Additional Benefit to Lifestyle Intervention on Cardiometabolic Status in Patients with Non-Alcoholic Fatty Liver Disease

Cardiovascular disease (CVD) is the leading cause of death in patients with non-alcoholic fatty liver disease (NAFLD). Curcumin has been shown to exert glucose-lowering and anti-atherosclerotic effects in type 2 diabetes. Hence, we investigated curcumin’s effects on atherogenesis markers, fatty live...

Descripción completa

Detalles Bibliográficos
Autores principales: Naseri, Kaveh, Saadati, Saeede, Yari, Zahra, Askari, Behzad, Mafi, Davood, Hoseinian, Pooria, Asbaghi, Omid, Hekmatdoost, Azita, de Courten, Barbora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370510/
https://www.ncbi.nlm.nih.gov/pubmed/35956400
http://dx.doi.org/10.3390/nu14153224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370510/
https://www.ncbi.nlm.nih.gov/pubmed/35956400
http://dx.doi.org/10.3390/nu14153224

Ejemplares similares